NATCO Pharma Limited (NSE:NATCOPHARM)

India · Delayed Price · Currency is INR

934.90

-81.00 (-7.97%)

Jun 1, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	39.40B	43.69B	38.91B	26.66B	19.40B
Pharmaceuticals Growth	-9.81%	12.30%	45.92%	37.44%	-5.37%
Agro Chemicals	1.38B	606.00M	1.08B	409.00M	49.00M
Agro Chemicals Growth	128.05%	-44.04%	164.79%	734.69%	133.33%
Total	40.78B	44.30B	39.99B	27.07B	19.45B
Total Growth	-7.93%	10.77%	47.72%	39.20%	-5.23%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	5.67B	5.88B	5.01B	6.09B
India Growth	-3.52%	17.19%	-17.67%	0.21%
United States of America (USA)	31.49B	28.05B	16.06B	9.78B
United States of America (USA) Growth	12.26%	74.65%	64.18%	23.67%
Rest of The World	7.14B	6.06B	6.00B	3.58B
Rest of The World Growth	17.73%	1.12%	67.70%	-45.27%
Total	44.30B	39.99B	27.07B	19.45B
Total Growth	10.77%	47.72%	39.20%	-5.23%

Source: S&P Global Market Intelligence.